To explore the efficacy and safety of durvalumab combined with cisplatin and docetaxel as neoadjuvant therapy in the treatment of locally advanced non-small cell lung cancer (NSCLC) patients.
This prospective, single-arm clinical study included twenty-five patients with locally advanced NSCLC from January 2020 to March 2021 who received durvalumab combined with cisplatin and docetaxel neoadjuvant therapy for 2 cycles before surgery. Then they received durvalumab monotherapy or combined with cisplatin and docetaxel adjuvant therapy after surgery. After discharge, patients were followed up every 1 to 2 months for the first six months and every 3 to 6 months thereafter. The primary outcome was pathological remission rate. Secondary outcome measures were clinical response rate, disease-free survival (DFS), and overall survival (OS).
The mean age of all enrolled patients was (59.84±7.14) years, including 18 males (72.00%) and 7 females (28.00%). The primary outcome indicated that 56% patients achieved significant pathological response, among which 24% achieved complete pathological response. The secondary outcome showed that 0, 60%, 36% and 4% patients achieved clinical complete response, partial response, disease stability and disease progression, and the overall objective response rate was 60%. The 1-year DFS was 79%, and the 1-year OS was 90%. There was no correlation of Eastern Cooperative Oncology Group performance status and TNM stage with DFS or OS. Besides, The most common adverse events were alopecia (48%), fatigue (40%), nausea and vomiting (36%). Most of the adverse events were at grade 1 to 2, only a few were at grade 3 to 4.
Durvalumab combined with cisplatin and docetaxel exhibits good efficacy profile as neoadjuvant therapy in locally advanced NSCLC patients.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |